Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/51101| Title: | Bioequivalence of doxazosin slow release tablets : a pilot study |
| Authors: | Attard, Alison Cilia, Mark Zammit, Marie Clare Wirth, Francesca Coleiro, Bernard Zarb Adami, Maurice Azzopardi, Lilian M. Serracino-Inglott, Anthony |
| Keywords: | Drugs -- Therapeutic equivalency Doxazosin -- Analysis Doxazosin -- Therapeutic use High performance liquid chromatography -- Methodology |
| Issue Date: | 2010-03 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Attard, A., Cilia, M., Zammit, M. C., Wirth, F., Coleiro, B., Zarb Adami, M.,…Serracino-Inglott, A. (2010, March). Bioequivalence of doxazosin slow release tablets: a pilot study. Poster session presented at the 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Valletta, Malta. |
| Abstract: | A poster presentation regarding a pilot study on the bioequivalence of doxazosin slow release tablets. Introduction: Bioequivalence studies are carried out to compare the systemic exposure profile of a test drug product to that of a reference product. Doxazosin is a potent quinazoline derivative and is effective for the treatment of hypertension and benign prostatic hyperplasia. Aim: To carry out a pilot bioequivalence study to assess comparative bioavailability between test product, doxazosin mesylate 8mg slow release tablets and reference product, Cardura®XL 8mg tablets. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/51101 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Bioequivalence_of_doxazosin_slow_release_tablets_a_pilot_study_2010.pdf | 1.1 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.